ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials

Journal of Pain and Symptom Management

Volumn 39, Issue 6, 2010, Pages 1086-1099

  Barsevick, Andrea M ^a   Cleeland, Charles S ^b   Manning, Donald C ^c   O'Mara, Ann M ^d   Reeve, Bryce B ^d   Scott, Jane A ^f   Sloan, Jeff A ^e  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHIONOGI AND CO LTD   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^f ADELPHI REAL WORLD   (United Kingdom)

Author keywords

Cancer related fatigue; clinical trials; patient reported outcomes; self report measures

Indexed keywords

ARTICLE; CANCER PATIENT; FATIGUE; FOOD AND DRUG ADMINISTRATION; HUMAN; ONCOLOGY; OUTCOME ASSESSMENT; RELIABILITY; SENSATION; SYMPTOMATOLOGY; VALIDITY; CLINICAL TRIAL; NEOPLASM; NOMENCLATURE; PATIENT; REVIEW; STANDARD; TREATMENT OUTCOME; UNITED STATES;

CLINICAL TRIALS AS TOPIC; FATIGUE; HUMANS; NEOPLASMS; PATIENTS; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77953183548     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.02.006     Document Type: Article

References (76)

1. Armes J. The experience of cancer-related fatigue. In: Armes J., Krishnasamy M., and Higginson I. (Eds). Fatigue in cancer (2004), Oxford University Press, Oxford, UK 137-155
2. Higginson I.J., Armes J., and Krishnasamy M. Introduction. In: Armes J., Krishnasamy M., and Higginson I. (Eds). Fatigue in cancer (2004), Oxford University Press, Oxford, UK xvii-xxi
3. ASCPRO. Assessing the symptoms of cancer using patient-reported outcomes. Available from. www.ASCPRO.org Accessed May 17, 2010
4. US Department of Health and Human Services. Guidance for industry, patient-reported outcome measures: Use in medical product development to support labeling claims (2009), US Food and Drug Administration, Rockville, MD
5. OMERACT. Outcome measures in rheumatology. Available from. www.intermed.med.uottawa.ca/research/omeract./ Accessed May 17, 2010
6. IMMPACT. Initiative on methods, measurement, and pain assessment in clinical trials. Available from. www.immpact.org/index.html Accessed May 17, 2010
7. Ream E., and Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud 34 1 (1997) 44-53
8. Krishnasamy M. Fatigue in advanced cancer-meaning before measurement?. Int J Nurs Stud 37 5 (2000) 401-414
9. Christodoulou C. The assessment and measurement of fatigue. In: DeLuca J. (Ed). Fatigue as a window to the brain (2005), The MIT Press, Cambridge, MA 19-35
10. Cella D., Davis K., Breitbart W., Curt G., and the Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19 14 (2001) 3385-3391
11. Ahlberg K., Ekman T., and Gaston-Johansson F. Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: a pilot study. Biol Res Nurs 5 3 (2004) 203-210
12. National Comprehensive Cancer Network. The cancer-related fatigue guidelines (Version 2.2007) (2006), National Comprehensive Cancer Network, Inc., Jenkintown, PA The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM].
13. Curt G.A., Breitbart W., Cella D., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5 5 (2000) 353-360
14. Dalakas M.C., Mock V., and Hawkins M.J. Fatigue: definitions, mechanisms, and paradigms for study. Semin Oncol 25 1 Suppl 1 (1998) 48-53
15. Iop A., Manfredi A.M., and Bonura S. Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 15 5 (2004) 712-720
16. Meek P.M., Nail L.M., Barsevick A., et al. Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 49 4 (2000) 181-190
17. Morrow G.R., Andrews P.L., Hickok J.T., et al. Fatigue associated with cancer and its treatment. Support Care Cancer 10 5 (2002) 389-398
18. ®) patient version. Available from. http://www.cancer.gov/cancertopics/pdq/supportivecare/fatigue/patient Accessed May 17, 2010
19. ®) health professional version. Available from. http://www.cancer.gov/cancertopics/pdq/supportivecare/fatigue/healthprof essional Accessed May 17, 2010
20. Okuyama T., Akechi T., Kugaya A., et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 19 1 (2000) 5-14
21. In: Eaton L.H., and Tipton J.M. (Eds). Putting evidence into practice: Improving oncology patient outcomes (2009), Oncology Nursing Society, Pittsburgh PA pp. 149-174
22. Piper B.F., Dibble S.L., Dodd M.J., et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25 4 (1998) 677-684
23. Schwartz A.L. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 25 4 (1998) 711-717
24. Spazzapan S., Bearz A., and Tirelli U. Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 15 10 (2004) 1576 [comment]
25. Wu H.S., and McSweeney M. Assessing fatigue in persons with cancer: an instrument development and testing study. Cancer 101 7 (2004) 1685-1695
26. Wu H.S., and McSweeney M. Cancer-related fatigue: "It's so much more than just being tired". Eur J Oncol Nurs 11 2 (2007) 117-125 [see comment]
27. Cella D., Peterman A., Passik S., Jacobsen P., and Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12 11A (1998) 369-377
28. Mitchell S.A., and Berger A.M. Cancer-related fatigue: the evidence base for assessment and management. Cancer J 12 5 (2006) 374-387
29. Morrow G.R., Shelke A.R., Roscoe J.A., et al. Management of cancer-related fatigue. Cancer Invest 23 3 (2005) 229-239
30. Portenoy R.K., and Itri L.M. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4 1 (1999) 1-10 [see comment] [comment]
31. Sadler I.J., Jacobsen P.B., Booth-Jones M., et al. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 23 5 (2002) 406-416
32. Van Belle S., Paridaens R., Evers G., et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer 13 4 (2005) 246-254
33. Nail L.M. Fatigue in patients with cancer. Oncol Nurs Forum 29 3 (2002) 537
34. National Comprehensive Cancer Network. The complete library of NCCN clinical practice guidelines in oncology (2009), National Comprehensive Cancer Network, Fort Washington, PA
35. Olson K. A new way of thinking about fatigue: a reconceptualization. Oncol Nurs Forum 34 1 (2007) 93-99
36. Nagel G.C., Schmidt S., Strauss B.M., and Katenkamp D. Quality of life in breast cancer patients: a cluster analytic approach. Empirically derived subgroups of the EORTC-QLQ BR 23-a clinically oriented assessment. Breast Cancer Res Treat 68 1 (2001) 75-87
37. Hotopf M. Definitions, epidemiology, and models of fatigue in the general population and in cancer. In: Armes J., Krishnasamy M., and Higginson I. (Eds). Fatigue in cancer (2004), Oxford University Press, Oxford, UK 3-27
38. Rhodes V.A., Watson P.M., and Hanson B.M. Patients' descriptions of the influence of tiredness and weakness on self-care abilities. Cancer Nurs 11 3 (1988) 186-194
39. Glaus A., Crow R., and Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care 5 2 Suppl (1996) 8-23
40. Wu H.S., and McSweeney M. Measurement of fatigue in people with cancer. Oncol Nurs Forum 28 9 (2001) 1371-1384 quiz 1385-1376
41. Holley S. Cancer-related fatigue. Suffering a different fatigue. Cancer Pract 8 2 (2000) 87-95
42. Barsevick A.M., Whitmer K., and Walker L. In their own words: using the common sense model to analyze patient descriptions of cancer-related fatigue. Oncol Nurs Forum 28 9 (2001) 1363-1369
43. Lai J.S., Cella D., Dineen K., et al. An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol 58 2 (2005) 190-197
44. Lai J.S., Crane P.K., Cella D., et al. Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue. Qual Life Res 15 7 (2006) 1179-1190 [erratum appears in Qual Life Res 2007;16(5):911]
45. Lai J.S., Kupst M.J., Cella D., et al. Using Q-methodology to understand perceived fatigue reported by adolescents with cancer. Psychooncology 16 5 (2007) 437-447
46. Dittner A.J., Wessely S.C., and Brown R.G. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 56 2 (2004) 157-170
47. Hjollund N.H., Andersen J.H., and Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 5 (2007) 12
48. Jacobsen P.B. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 93-97
49. Jean-Pierre P., Figueroa-Moseley C.D., Kohli S., et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12 Suppl 1 (2007) 11-21
50. Minton O., and Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20 1 (2009) 17-25
51. Mota D.D., and Pimenta C.A. Self-report instruments for fatigue assessment: a systematic review. Res Theory Nurs Pract 20 1 (2006) 49-78
52. Frost M.H., Reeve B.B., Liepa A.M., et al. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?. Value Health 10 Suppl 2 (2007) S94-S105
53. Broderick J.E., Schwartz J.E., Vikingstad G., et al. The accuracy of pain and fatigue items across different reporting periods. Pain 139 1 (2008) 146-157
54. Butt Z., Wagner L.I., Beaumont J.L., et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 35 1 (2008) 20-30
55. Garcia S.F., Cella D., Clauser S.B., et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25 32 (2007) 5106-5112
56. Hays R.D., and Woolley J.M. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?. Pharmacoeconomics 18 5 (2000) 419-423
57. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10 4 (1989) 407-415
58. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47 1 (1994) 81-87
59. Schwartz A.H. Validity of cancer-related fatigue instruments. Pharmacotherapy 22 11 (2002) 1433-1441
60. Sloan A.J., Cella D., Frost M., et al. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 77 4 (2002) 367-370
61. National Institutes of Health. Glossary of NIH terms. Available from. http://grants.nih.gov/grants/glossary/.htm/ Accessed August 4, 2009
62. National Institutes of Health. Clinical trials.gov registry. Available from. www.clinicaltrials.gov Accessed August 3, 2009
63. Burke L.B., Kennedy D.L., Miskala P.H., Papadopoulos E.J., and Trentacosti A.M. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 84 2 (2008) 281-283
64. Cella D., Eton D.T., Lai J.S., et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24 6 (2002) 547-561
65. Goligher E.C., Pouchot J., Brant R., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 35 4 (2008) 635-642
66. Pouchot J., Kherani R.B., Brant R., et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 61 7 (2008) 705-713
67. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85 5 (1999) 1186-1196
68. Cella D., Lai J.S., Chang C.H., Peterman A., and Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94 2 (2002) 528-538
69. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 10 (1989) 1121-1123
70. Lee K.A., Hicks G., and Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 36 3 (1991) 291-298
71. Belza B.L. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 22 4 (1995) 639-643
72. Smets E.M., Garssen B., Bonke B., and De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39 3 (1995) 315-325
73. Stein K.D., Martin S.C., Hann D.M., and Jacobsen P.B. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6 3 (1998) 143-152
74. Rhoten D. Fatigue and the post-surgical patient. In: Norris C.M. (Ed). Concept clarification in nursing (1982), Aspen Publishers, Inc., Rockville, MD 277-300
75. Ware Jr. J.E., Snow K.K., Kosinski M., and Gandek B. SF-36 Health Survey manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston, MA
76. Medical Outcomes Trust, SAC. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11 3 (2002) 193-205